News · PROTAC
23 stories
Oct 8, 26STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines
Oct 8, 26Ono pays $80M for regional rights to trio of Biohaven IgG degraders, including phase 3 Grave’s asset
23 stories